Evaluation of the Dose-Response Relationship of Amlodipine and Losartan Combination in Patients with Essential Hypertension-Reference-Cited by-同舟云学术

Evaluation of the Dose-Response Relationship of Amlodipine and Losartan Combination in Patients with Essential Hypertension

Published:2012-02 Issue:1 Volume:12 Page:35-47
ISSN:1175-3277
Container-title:American Journal Cardiovascular Drugs
language:en
Short-container-title:American Journal Cardiovascular Drugs

Author:

Park Chang-Gyu,Youn Ho-Joong,Chae Shung-Chull,Yang Joo-Young,Kim Moo-Hyun,Hong Taek-Jong,Kim Cheol Ho,Kim Jae Joong,Hong Bum-Kee,Jeong Jin-Won,Park Si-Hoon,Kwan Jun,Choi Young-Jin,Cho Seung-Yun

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cardiology and Cardiovascular Medicine,General Medicine

Reference29 articles.

1. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

2. Essential hypertension

3. Executive Summary: Heart Disease and Stroke Statistics—2010 Update

4. The Search for Strategies to Control Hypertension

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Low-Dose Triple Antihypertensive Combination Therapy in Patients with Hypertension: A Randomized, Double-Blind, Phase II Study;Drug Design, Development and Therapy;2020-12

Comparison of Pharmacokinetics of a Fixed-Dose Combination of Amlodipine/Losartan/Rosuvastatin with Concomitant Administration of Amlodipine/Losartan and Rosuvastatin in Healthy Volunteers

;Drug Design, Development and Therapy;2020-02

3. Systematic Review with Network Meta-Analysis: Comparative Efficacy and Safety of Combination Therapy with Angiotensin II Receptor Blockers and Amlodipine in Asian Hypertensive Patients;International Journal of Hypertension;2019-11-11

4. The influence of Losartanum and Amlodipinum fixed combination use on cardiovascular complications risk factors seasonal variability in patients with arterial hypertension;Systemic Hypertension;2017-12-15

5. A Randomized, Multicenter, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and the Tolerability of a Triple Combination of Amlodipine/Losartan/Rosuvastatin in Patients With Comorbid Essential Hypertension and Hyperlipidemia;Clinical Therapeutics;2017-12